参考文献/References:
[1] COLE ZA,DENNISON EM,COOPER C.Osteoporosis epidemiology update[J].Curr Rheumatol Rep,2008,10(2):92-96.
[2] 陈林,程军,李波,等.渝东北地区老年人骨质疏松流行病学调查[J].中国骨质疏松杂志,2016,22(8):1050-1052.
[3] 刘峰.骨质疏松流行病学及防治研究进展[J].医学理论与实践,2017,30(22):3321-3322.
[4] 韩亚军,帖小佳,伊力哈木·托合提.中国中老年人骨质疏松症患病率的Meta分析[J].中国组织工程研究,2014,18(7):1129-1134.
[5] 乔芳,常静.骨质疏松流行病学调查分析[J].中国实用医药,2012,7(30):271-272.
[6] QIN J,LI R,RAES J,et al.A human gut microbial gene catalogue established by metagenomic sequencing[J].Nature,2010,464(7285):59-65.
[7] VITAL M,HOWE AC,TIEDJE JM.Revealing the bacterial butyrate synthesis pathways by analyzing(meta)genomic data[J].MBio,2014,5(2):889.
[8] FRANSEN F,VAN BEEK AA,BORGHUIS T,et al.Aged Gut Microbiota Contributes to Systemical Inflammaging after Transfer to Germ-Free Mice[J].Front Immunol,2017,8:1385.
[9] LERNER A,NEIDHÖFER S,MATTHIAS T.The Gut Microbiome Feelings of the Brain:A Perspective for Non-Microbiologists[J].Microorganisms,2017,5(4):66.
[10] LAHTI L,SALOJÄRVI J,SALONEN A,et al.Tipping elements in the human intestinal ecosystem[J].Nat Commun,2014,5:4344.
[11] OHLSSON C,ENGDAHL C,FÄK F,et al.Probiotics protect mice from ovariectomy-induced cortical bone loss[J].PLoS One,2014,9(3):92368.
[12] NOVINCE CM,WHITTOW CR,AARTUN JD,et al.Commensal Gut Microbiota Immunomodulatory Actions in Bone Marrow and Liver have Catabolic Effects on Skeletal Homeostasis in Health[J].Sci Rep,2017,7(1):5747.
[13] CHUNG HJ,KYUNG KIM W,JOO PARK H,et al.Anti-osteoporotic activity of harpagide by regulation of bone formation in osteoblast cell culture and ovariectomy-induced bone loss mouse models[J].J Ethnopharmacol,2016,179:66-75.
[14] BUCHET R,MILLÁN JL,MAGNE D.Multisystemic functions of alkaline phosphatases[J].Methods Mol Biol,2013,1053:27-51.
[15] CHEN YC,GREENBAUM J,SHEN H,et al.Association Between Gut Microbiota and Bone Health:Potential Mechanisms and Prospective[J].J Clin Endocrinol Metab,2017,102(10):3635-3646.
[16] EJTAHED HS,SOROUSH AR,ANGOORANI P,et al.Gut Microbiota as a Target in the Pathogenesis of Metabolic Disorders:A New Approach to Novel Therapeutic Agents[J].Horm Metab Res,2016,48(6):349-358.
[17] MCCABE L,BRITTON RA,PARAMESWARAN N.Prebiotic and Probiotic Regulation of Bone Health:Role of the Intestine and its Microbiome[J].Curr Osteoporos Rep,2015,13(6):363-371.
[18] KWAN TAT S,PADRINES M,THÉOLEYRE S,et al.IL-6,RANKL,TNF-alpha/IL-1:interrelations in bone resorption pathophysiology[J].Cytokine Growth Factor Rev,2004,15(1):49-60.
[19] KANIS JA,MCCLOSKEY EV,JOHANSSON H,et al.European guidance for the diagnosis and management of osteoporosis in postmenopausal women[J].Osteoporos Int,2013,24(1):23-57.
[20] GÓMEZ NAVARRO R.Use of the FRAX algorithm to calculate the fracture risk in women of a rural area[J].Rev Esp Salud Publica,2010,84(3):321-330.
[21] LEKAMWASAM S,ADACHI JD,AGNUSDEI D,et al.A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis[J].Osteoporos Int,2012,23(9):2257-2276.
[22] 周年,刘波,徐彭.氧化应激与骨质疏松症的研究进展[J].中国骨质疏松杂志,2014,20(12):1485-1489.
[23] 张鲲,陈晓亮.氧化应激与骨质疏松[J].中国骨质疏松杂志,2006,12(5):535-537.
[24] CHAPPLE SJ,PUSZYK WM,MANN GE.Keap1-Nrf2 regulated redox signaling in utero:Priming of disease susceptibility in offspring[J].Free Radic Biol Med,2015,88(Pt B):212-220.
[25] AGARWAL A,APONTE-MELLADO A,PREMKUMAR BJ,et al.The effects of oxidative stress on female reproduction:a review[J].Reprod Biol Endocrinol,2012,10:49.
[26] MANOLAGAS SC.From estrogen-centric to aging and oxidative stress:a revised perspective of the pathogenesis of osteoporosis[J].Endocr Rev,2010,31(3):266-300.
[27] PANSINI F,MOLLICA G,BERGAMINI CM.Management of the menopausal disturbances and oxidative stress[J].Curr Pharm Des,2005,11(16):2063-2073.
[28] LEAN JM,DAVIES JT,FULLER K,et al.A crucial role for thiol antioxidants in estrogen-deficiency bone loss[J].J Clin Invest,2003,112(6):915-923.
[29] MEDEMA RH,KOPS GJ,BOS JL,et al.AFX-like Forkhead transcription factors mediate cell-cycle regulation by Ras and PKB through p27kip1[J].Nature,2000,404(6779):782-787.
中医正骨2018年3月第30卷第3期 J Trad Chin Orthop Trauma,2018,Vol.30,No.3(总215)
(总216)中医正骨2018年3月第30卷第3期 J Trad Chin Orthop Trauma,2018,Vol.30,No.3
[30] TRAN H,BRUNET A,GRENIER JM,et al.DNA repair pathway stimulated by the forkhead transcription factor FOXO3a through the Gadd45 protein[J].Science,2002,296(5567):530-534.
[31] KOPS GJ,DANSEN TB,POLDERMAN PE,et al.Forkhead transcription factor FOXO3a protects quiescent cells from oxidative stress[J].Nature,2002,419(6904):316-321.
[32] VILLATE O,TURATSINZE JV,MASCALI LG,et al.Nova1 is a master regulator of alternative splicing in pancreatic beta cells[J].Nucleic Acids Res,2014,42(18):11818-11830.
[33] BRUNET A,BONNI A,ZIGMOND MJ,et al.Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor[J].Cell,1999,96(6):857-868.
[34] POLVANI S,TAROCCHI M,GALLI A.PPARγ and Oxidative Stress:Con(β)Catenating NRF2 and FOXO[J].PPAR Res,2012,2012:641087.
[35] HOOGEBOOM D,ESSERS MA,POLDERMAN PE,et al.Interaction of FOXO with beta-catenin inhibits beta-catenin/T cell factor activity[J].J Biol Chem,2008,283(14):9224-9230.
[36] POUYET L,CARRIER A.Mutant mouse models of oxidative stress[J].Transgenic Res,2010,19(2):155-164.
[37] ESSERS MA,DE VRIES-SMITS LM,BARKER N,et al.Functional interaction between beta-catenin and FOXO in oxidative stress signaling[J].Science,2005,308(5725):1181-1184.
[38] HOOGEBOOM D,BURGERING BM.Should I stay or should I go:beta-catenin decides under stress[J].Biochim Biophys Acta,2009,1796(2):63-74.
[39] ALMEIDA M.Unraveling the role of FoxOs in bone—insights from mouse models[J].Bone,2011,49(3):319-327.
[40] ALMEIDA M,HAN L,AMBROGINI E,et al.Glucocorticoids and tumor necrosis factor α increase oxidative stress and suppress Wnt protein signaling in osteoblasts[J].J Biol Chem,2011,286(52):44326-44335.
[41] OH J,HUR MW,LEE CE.SOCS1 protects protein tyrosine phosphatases by thioredoxin upregulation and attenuates Jaks to suppress ROS-mediated apoptosis[J].Oncogene,2009,28(35):3145-3156.
[42] KUANG W,ZHENG L,XU X,et al.Dysregulation of the miR-146a-Smad4 axis impairs osteogenesis of bone mesenchymal stem cells under inflammation[J].Bone Res,2017,5:17037.
[43] KIM HK,LEE JS,KIM JH,et al.Bone-forming peptide-2 derived from BMP-7 enhances osteoblast differentiation from multipotent bone marrow stromal cells and bone formation[J].Exp Mol Med,2017,49(5):328.
[44] BALANI DH,ONO N,KRONENBERG HM.Parathyroid hormone regulates fates of murine osteoblast precursors in vivo[J].J Clin Invest,2017,127(9):3327-3338.
[45] VAN DE PEPPEL J,STRINI T,TILBURG J,et al.Identification of Three Early Phases of Cell-Fate Determination during Osteogenic and Adipogenic Differentiation by Transcription Factor Dynamics[J].Stem Cell Reports,2017,8(4):947-960.
[46] ZHOU BO,YU H,YUE R,et al.Bone marrow adipocytes promote the regeneration of stem cells and haematopoiesis by secreting SCF[J].Nat Cell Biol,2017,19(8):891-903.
[47] WU M,WANG Y,SHAO JZ,et al.Cbfβ governs osteoblast-adipocyte lineage commitment through enhancing β-catenin signaling and suppressing adipogenesis gene expression[J].Proc Natl Acad Sci USA,2017,114(38):10119-10124.
[48] DEBRUINE ZJ,XU HE,MELCHER K.Assembly and architecture of the Wnt/β-catenin signalosome at the membrane[J].Br J Pharmacol,2017,174(24):4564-4574.
[49] DEBRUINE ZJ,KE J,HARIKUMAR KG,et al.Wnt5a promotes Frizzled-4 signalosome assembly by stabilizing cysteine-rich domain dimerization[J].Genes Dev,2017,31(9):916-926.
[50] YANG N,LI Y,WANG G,et al.Tumor necrosis factor-α suppresses adipogenic and osteogenic differentiation of human periodontal ligament stem cell by inhibiting miR-21/Spry1 functional axis[J].Differentiation,2017,97:33-43.
[51] ZHANG L,TANG Y,ZHU X,et al.Overexpression of MiR-335-5p Promotes Bone Formation and Regeneration in Mice[J].J Bone Miner Res,2017,32(12):2466-2475.
[52] ANASTASILAKIS AD,POLYZOS SA,MAKRAS P,et al.Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass:the 3-month effect of zoledronic acid,denosumab or teriparatide treatment[J].Expert Opin Ther Targets,2015,19(3):299-306.
[53] ZHANG Y,FENG E,XU Y,et al.Serum Sema4D levels are associated with lumbar spine bone mineral density and bone turnover markers in patients with postmenopausal osteoporosis[J].Int J Clin Exp Med,2015,8(9):16352-16357.
[54] 张韬,陈冬冬,翁艳,等.Sema4D基因沉默对骨髓间充质干细胞成骨及成脂肪分化相关基因表达的影响[J].厦门大学学报(自然科学版),2017,56(2):173-177.
[55] 李冠彗,李灿东,李西海,等.雌激素调控绝经后骨质疏松症骨吸收-骨形成耦联失衡的机制[J].中医正骨,2016,28(2):36-40.
相似文献/References:
[1]李林军.应用膨胀式椎弓根螺钉内固定治疗合并骨质疏松的
胸腰椎退行性疾病[J].中医正骨,2015,27(08):49.
[2]李学朋,朱立国.骨疏康胶囊对去卵巢大鼠骨小梁的影响[J].中医正骨,2015,27(12):12.
LI Xuepeng,ZHU Liguo.Effect of Gushukang Jiaonang(骨疏康胶囊)on bone trabecula in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):12.
[3]陈冠军,陈扬,庄汝杰.可灌注骨水泥椎弓根螺钉系统
在老年腰椎疾患手术中的应用[J].中医正骨,2015,27(02):40.
[4]王丹辉,贲越,韩梅.林蛙油治疗绝经后骨质疏松症的临床研究[J].中医正骨,2014,26(01):27.
Wang Danhui*,Ben Yue,Han Mei..Clinical study of Rana temporaria oil in the treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):27.
[5]黄建华,黄建武,李慧辉,等.加味左归丸对绝经后骨质疏松症肝肾不足证
患者骨密度的影响[J].中医正骨,2013,25(11):19.
Huang Jianhua*,Huang Jianwu,Li Huihui,et al.Effect of JIAWEI ZUOGUI pill on bone mineral density in postmenopausal osteoporosis patients with deficiency of liver and kidney[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):19.
[6]项旻,杨虹,林爱菊,等.绝经后2型糖尿病患者骨质疏松与血微量元素的关系研究[J].中医正骨,2013,25(12):20.
Xiang Min*,Yang Hong,Lin Aiju,et al.Clinical study on the relationship between osteoporosis and serum trace elements levels in postmenopausal women with type 2 diabetes[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2013,25(03):20.
[7]史晓林,李春雯,张志强.弱阳离子磁珠分离技术和基质辅助激光解吸电离飞行时间质谱技术在原发性Ⅰ型骨质疏松症血清标志蛋白筛选中的应用[J].中医正骨,2014,26(03):5.
Shi Xiaolin*,Li Chunwen,Zhang Zhiqiang..Application of magnetic beads based weak cation exchange separation technology and matrix-assisted laser desorption-ionization time of flight mass spectrometry technology in screening serum protein markers of primary type-Ⅰ osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):5.
[8]李明,徐明雄,冯左基,等.自拟壮骨方治疗绝经后骨质疏松症的疗效及作用机制研究[J].中医正骨,2014,26(09):21.
Li Ming*,Xu Mingxiong,Feng Zuoji,et al.Study on the curative effect and mechanism of action of self-made ZHUANGGU decoction in treatment of postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2014,26(03):21.
[9]陈俊杰,李晴晴,夏瑢.脂代谢及血清内脂素水平与绝经后骨质疏松症的
相关性研究[J].中医正骨,2012,24(04):16.
CHEN Jun-jie*,LI Qing-qing,XIA Rong.*.Study on the correlations between the levels of lipid metabolism and serum visfatin and postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2012,24(03):16.
[10]许超,肖鲁伟,吴承亮.绝经后女性骨质疏松症辨证分型与抑郁焦虑的关系研究[J].中医正骨,2011,23(12):3.
XU Chao*,XIAO Lu-wei,WU Cheng-liang.*.Study on the relationship between the syndrome differ classification and the depression and anxiety for the postmenopausal women with osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2011,23(03):3.
[11]韩艳,温利平,刘娜,等.补肾活血方对去卵巢大鼠骨代谢及骨密度的影响[J].中医正骨,2015,27(12):7.
HAN Yan,WEN Liping,LIU Na,et al.Effect of Bushen Huoxue Fang(补肾活血方)on bone metabolism and bone mineral density in the ovariectomized rats[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(03):7.
[12]欧国峰,刘鑫,董博,等.绝经后骨质疏松症的免疫学研究进展[J].中医正骨,2016,28(08):70.
[13]施振宇,刘钟,陈文亮,等.中医综合疗法防治绝经后骨量减少的多中心临床研究[J].中医正骨,2017,29(04):1.
SHI Zhenyu,LIU Zhong,CHEN Wenliang,et al.A multicenter clinical study of complex therapy of traditional Chinese medicine for prevention and treatment of postmenopausal osteopenia[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(03):1.
[14]梁文娜,李西海,李灿东.血清microRNA与绝经后骨质疏松症肾虚证的关系[J].中医正骨,2017,29(10):53.
[15]梁文娜,李西海,胡柳,等.二至丸抑制绝经后骨质疏松大鼠骨代谢紊乱的作用机制研究[J].中医正骨,2017,29(11):1.
LIANG Wenna,LI Xihai,HU Liu,et al.Study on mechanism of action of Erzhi Wan(二至丸)in inhibiting bone metabolism disorder in rats with postmenopausal osteoporosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2017,29(03):1.
[16]杨依然,刘钟,毛一凡,等.酪蛋白激酶-2相互作用蛋白1基于磷脂酰肌醇3-激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白通路参与绝经后骨质疏松症发生发展过程中细胞自噬的机制[J].中医正骨,2018,30(04):59.
[17]曹俊青,郑剑南,张麟.右归丸联合阿仑膦酸钠口服治疗绝经后骨质疏松症肾阳虚证的临床研究[J].中医正骨,2018,30(05):20.
CAO Junqing,ZHENG Jiannan,ZHANG Lin.A clinical study of oral application of Yougui Wan(右归丸)and alendronate sodium for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(03):20.
[18]李中万,徐绍俊,杨广钢,等.健肾方联合碳酸钙D3咀嚼片(Ⅱ)
治疗绝经后骨质疏松症肾阳虚证[J].中医正骨,2018,30(08):11.
LI Zhongwan,XU Shaojun,YANG Guanggang,et al.Oral application of Jianshen Fang(健肾方)and calcium carbonate and Vitamin D3 chewable tablets(Ⅱ)for treatment of postmenopausal osteoporosis with kidney-yang deficiency syndrome[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2018,30(03):11.
[19]赵凡,刘全,吴连国.口服强骨饮联合碳酸钙D3片治疗绝经后骨质疏松症的临床研究[J].中医正骨,2019,31(04):26.
ZHAO Fan,LIU Quan,WU Lianguo.Oral applications of Qianggu Yin(强骨饮)and calcium carbonate and Vitamin D3 tablets for treatment of postmenopausal osteoporosis:a clinical study[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(03):26.
[20]史晓林,杨依然,刘钟,等.基于蛋白质组学方法分析绝经后骨质疏松症全血差异蛋白[J].中医正骨,2019,31(06):7.
SHI Xiaolin,YANG Yiran,LIU Zhong,et al.Analysis of proteins which are differentially expressed in whole blood of patients with postmenopausal osteoporosis using proteomics approach[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2019,31(03):7.